|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 1.50|
Dr. Kimothy Smith discusses importance of point of care/point of need detection during flu season
Disruptive Diagnostic Testing at the Point of Need May Offer Important Defense Against Dangerous Flu Season
ENG's mobile labs represent the fastest growing segment of ENG's specialty vehicle business
Company expects year-over-year growth of over 30% for the 2017 fourth quarter and 2018 first quarter
Chairman and CEO William J. Caragol discusses projected consolidated year-over-year revenue growth of more than 30% for the 2017 fourth quarter and 2018 first quarter
ExcitePCR's FireflyDX is designed to bring lab-based testing to the point of need for real-time biological threat detection in less than 30 minutes
Bluetooth-enabled Caregiver Device Holds Potential to Disrupt the $1 Billion Thermometry Market
Company Has a Strong Backlog of Business in its Mobile Labs and Medical Device Segments
Company also improves operating results, reducing operating loss 74% for the third quarter of 2017 from the third quarter of 2016
Company projects that a product like ExcitePCR's FireflyDX could transform the $28 billion global point-of-care diagnostics market
ENG's new drone initiative to enable real-time communication in challenging environments and help deliver market edge
ENG has delivered more than 1,500 vehicles to customers around the world and earned more than $5 million in revenue in 2016
Dr. R. Paul Schaudies, Charles Pick and Dr. Anilrudh Venugopal bring broad industry expertise and skilled leadership to ExcitePCR to help drive commercialization of FireflyDX
Three-person BioWatch panel on current and future advancements in pathogen detection systems will be held at 3:30 pm in Washington, D.C.
Press Conference to be Held on September 18th at the National Press Club in Washington, D.C.
Sixty-minute panel about current and future advancements in pathogen detection systems to be held at 3:30 p.m. (ET) on Mon., Sept. 18 at the National Academy of Sciences in Washington, D.C.
Recent market developments inspire ExcitePCR management to expand its product strategy to a planned rollout of a FireflyDX family of realtime pathogen detection systems, with the FireflyDX-Portable launch scheduled for the summer of 2018 and the FireflyDX-Handheld targeted for availability in 2019
Mobile labs revenues represent more than 50% of total revenue for its specialty vehicle business, up from 24% for the full year 2016
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.